DevelRx are experts in the development of drugs to treat psychiatric disorders. As part of RenaSci, we supported the development of lisdexamfetamine for the treatment of binge-eating disorder (BED). We have recently performed a comprehensive review of all available clinical trials of drugs being developed for this condition. Our findings have been published in the International Journal of Obesity
Heal, D.J., Gosden, J. What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials. Int J Obes 2022 Jan 7
You can read the full article by clicking here
Please contact us to explore how we can facilitate the development of your new drugs to treat binge-eating disorder.